Virginia Acha

Executive director - Research, Medical and Innovation, Association of the British Pharmaceutical Industry

Recent stories

  • Countering points made in biosimilars piece

    30 JAN 2017

    The insight article by Alan Cassels ‘Why biosimilars should be interchangeable with biologics’ (Clinical Pharmacist 2017;9:2) provides a great opportunity to clarify some key points. I would like to counter some of the points made in Cassels’ piece — criticisms he says are used to slow down or derail the use of biosim

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.